By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Janssen Biotech Inc. 

800 Ridgeview Drive

Horsham  Pennsylvania  19044  U.S.A.
Phone: 888-227-5624 Fax: n/a


Company News
Aduro Biotech (ADRO) Receives Milestone Payment From Janssen Biotech Inc. (JNJ) For Submission Of Investigational New Drug Application For ADU-214 In Lung Cancer 10/9/2015 9:32:58 AM
Geron Corporation (GERN) Announces Initiation Of Janssen Biotech Inc. (JNJ) Phase 2 Clinical Trial Of Imetelstat In Myelofibrosis 9/16/2015 6:16:15 AM
Janssen Biotech Inc. (JNJ) Release: IMBRUVICA (ibrutinib) Supplemental New Drug Application For Treatment-Naive Chronic Lymphocytic Leukemia Submitted To The U.S. FDA 9/14/2015 7:18:13 AM
Janssen Biotech Inc. (JNJ) Release: U.S. FDA Approves Update Of SIMPONI ARIA (golimumab for infusion) Label To Include Improvement In Both Physical And Emotional Measures Of Health When Treating Moderately To Severely Active Rheumatoid Arthritis 9/2/2015 7:55:59 AM
Poseida Therapeutics Announces Worldwide License Agreement With Janssen Biotech Inc. (JNJ) To Apply Centyrin Technology In The Development Of Chimeric Antigen Receptor (CAR) Therapies 8/11/2015 8:05:39 AM
Janssen Biotech Inc. (JNJ) Release: Daratumumab Expanded Access Program Open To Eligible U.S. Patients With Heavily Pre-Treated Multiple Myeloma 7/6/2015 7:32:01 AM
Genmab A/S (GEN.CO) Achieves USD 10 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 4/17/2015 8:00:32 AM
Amphivena Therapeutics Achieves Development Milestones Under Agreement With Janssen Biotech Inc. (JNJ) 4/7/2015 10:11:17 AM
Affimed Therapeutics AG (AFMD) Completes Tandab Development Candidate Activities Meeting Amphivena's And Janssen Biotech Inc. (JNJ)'s Criteria And Achieves Milestone Ahead Of Schedule 3/24/2015 7:22:57 AM
Halozyme Therapeutics, Inc. (HALO) Reports Selection Of First Product Candidate Under Janssen Biotech Inc. (JNJ) Collaboration 3/10/2015 7:45:56 AM